News

IOCB Tech Presented CDK9 Inhibitor Project at MATWIN Oncology Conference in Bordeaux

07/05/2025
A research team team led by Michal Tichy and supported by IOCB Tech presented its CDK9 inhibitor project to the MATWIN board during the oncology-focused MATWIN annual conference in Bordeaux, France. The MATWIN initiative, a key French open-innovation platform in oncology, brings together representatives from academia, major pharmaceutical companies, and clinical research institutions.   Read more

Participation of Czech Scientific Teams at BioVaria 2025 Confirmed the Strength of Czech Research

29/04/2025
Czech research institutions presented several technological innovations with application potential in the fields of medicine and diagnostics at this year's BioVaria in Munich. IOCB Tech, in cooperation with the Institute of Organic Chemistry and Biochemistry of the CAS, i&i Prague, Prague.bio, the Institute of Physics of the CAS, the University of Chemistry and Technology in Prague, and the Faculty of Science of Charles University, actively showcased the results of Czech research at the traditional biotechnology conference within the Pitch & Partner and Investors' Forum sessions.   Read more

Czech biotechnologies presented in Milan

25/03/2025
Companies affiliated with the IOCB Tech group showcased their know-how and services at the traditional spring gathering of the biotech industry - BIO-Europe Spring, held this year in Milan, Italy. With nearly 4,000 experts from the fields of pharmaceuticals, biotechnology, and investment, the event serves as a platform for establishing strategic partnerships and presenting Czech innovations. Read more

Prof. Martin Fusek Appointed Member of the Czech Government’s Research, Development, and Innovation Council

15/11/2024
IOCB Tech is pleased to announce that Prof. Ing. Martin Fusek, CSc., has been appointed as a member of the Research, Development, and Innovation Council (RVVI) by the Office of the Government of the Czech Republic. This prestigious appointment reflects Prof. Fusek’s longstanding contributions to science and innovation, particularly in the field of technology transfer. Read more

Representatives of IOCB Tech Family Join Business Mission with the President of the Czech Republic to Switzerland

06/11/2024
Representatives from IOCB Tech Family will participate in a business mission accompanying the President of the Czech Republic, Petr Pavel, on his state visit to Switzerland from November 5 to 7, 2024. Organized by the Czech Chamber of Commerce, this delegation aims to strengthen both commercial and research relationships between the Czech Republic and Switzerland, particularly in the fields of biotechnology, pharmaceuticals, and innovation. Read more

From “Dancing Queen” to Drug Development: IOCB Tech Family and Prague.bio Spotlight Czech Biotech Innovation at BIO-Europe in Stockholm

05/11/2024
Celebrating 30 years of fostering global partnerships in the life sciences, this year’s BIO-Europe conference has taken on a distinctly Swedish flavour with a special nod to ABBA. The iconic biotech gathering, nowadays held in Stockholm is not only a celebration of three decades of collaboration but also a showcase of innovation at the heart of the industry. The IOCB Tech Family, Prague.bio and other companies are proud to represent the Czech biotech sector at this landmark event, where ABBA-themed sessions are sparking creative discussions and new partnerships. Read more

IOCB Tech Remains a Leading Diamond of Czech Business

24/10/2024
IOCB Tech has once again secured a top position in the prestigious Diamanty českého byznysu (Diamonds of Czech Business) ranking, reinforcing its status as a consistent leader in the Czech business landscape. This repeated recognition celebrates not only IOCB Tech's commitment to excellence in technology transfer but also underscores the significance of the entire field within the national economy. Read more

IOCB Tech attended Asia’s Leading Biotechnology Event, BioJapan 2024

10/10/2024
IOCB Tech, a leading technology transfer office in the Czech Republic, proudly attended BioJapan 2024, the largest and most influential biotechnology partnering event in Asia. Held at the Pacifico Yokohama Convention Center, this prestigious event brought together global leaders in biotechnology, regenerative medicine, and digital health, providing an ideal platform for collaboration between industry, academia, and government. Read more

The 10th Anniversary of a Prestigious Summer School Focused on Drug Development begins in Prague

02/09/2024
How can we accelerate the search for new drugs and bring discoveries in this field to market? These critical questions are addressed for the tenth time at the Prague-Weizmann Summer School on Advances in Drug Discovery. This event connects young scientists with leading experts from global pharmaceutical companies and academia, uniting all key parts of the chain that leads to essential medicines. The event, which has gained international recognition over the past decade, is organized by the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB), the University of Chemistry and Technology in Prague (UCT), and Israel's Weizmann Institute of Science. Read more